Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

China · Delayed Price · Currency is CNY

27.32

-0.06 (-0.22%)

Sep 1, 2026, 3:00 PM CST

-14.49% (1Y)

Market Cap	12.68B -14.3%
Revenue (ttm)	5.92B -6.1%
Net Income	101.76M
EPS	0.22
Shares Out	463.26M
PE Ratio	125.01
Forward PE	27.80
Dividend	0.88 (3.04%)
Ex-Dividend Date	Feb 5, 2026

Volume	7,998,720
Open	27.15
Previous Close	27.38
Day's Range	26.99 - 27.59
52-Week Range	21.50 - 40.68
Beta	0.37
Analysts	Buy
Price Target	31.19 (+14.17%)
Earnings Date	Aug 25, 2026

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logistics, and other services, as well as sells diagnostic products. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2006

Employees 9,529

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603882

Full Company Profile

Financial Performance

In 2025, SHA:603882's revenue was 6.03 billion, a decrease of -16.12% compared to the previous year's 7.19 billion. Losses were -173.24 million, -54.56% less than in 2024.

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for 603882 stock is "Buy." The 12-month stock price target is ¥31.19, which is an increase of 14.17% from the latest price.

Price Target

¥31.19

(14.17% upside)

Analyst Consensus: Buy

Stock Forecasts